focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

29 Jun 2021 16:49

RNS Number : 5437D
U and I Group PLC
29 June 2021
 

U and I Group PLC makes awards under its Long Term Incentive Plan 2014

 

U and I Group PLC (the Company) announces that the Remuneration Committee has granted options over ordinary shares to Executive Directors of the Company under its Long Term Incentive Plan 2014 (the Plan), which was approved by shareholders at the Annual General Meeting on 16 July 2014.

In accordance with the rules of the Plan, LTIP awards were granted on 28 June 2021 at the price of 97.44 pence per share, being the mathematical average mid-market price over the 5 dealing days from 15 June to 21 June 2021.

Options over ordinary shares have been granted to the following Executive Directors as follows:

 

Richard Upton

359,195

Jamie Christmas

307,881

 

Awards will be made on the basis that shares will be acquired subject to the satisfaction of the performance condition. The aim of which is to link the receipt of shares under the Plan to an improvement in the performance of the Company over a three and four-year performance period from 1 April 2021.

 

Performance Condition

 

1 An Award will (subject to paragraphs 4 and 5 below) Vest as to 50% by reference to the NAV Growth measure as set out in paragraph 2 below (and for which the Normal Vesting Date will be 28 June 2025) and as to 50% by reference to the Share Price measure as set out in paragraph 3 below (and for which the Normal Vesting Date will be 28 June 2024).

2 NAV Growth will be measured over the Performance Period and the percentage of the Award subject to the NAV Growth measure will Vest (subject to paragraph 4 and 5 below) to the extent set out in the table below, where:

"NAV Growth" means the cumulative growth in the diluted net assets per share of the Company (as reported in the Group's consolidated balance sheet) taking into account dividends over the Performance Period, as determined by the Directors.  The Directors may adjust the calculation of NAV Growth as they consider appropriate.

"Performance Period" means 1 April 2021 to 31 March 2025.

Percentage of Award subject to the NAV Growth measure that will Vest

NAV Growth over the Performance Period

0%

Less than 15.8%

20%

15.8%

Between 20% and 100% determined on a straight-line basis

Between 15.8% and 40.5%

100%

40.5% or more

 

Note: the targets for NAV Growth are equivalent to annual growth of 5% pa (for 20% vesting) and 12% pa (for 100% vesting).

3 The percentage of the Award subject to the Share Price measure will Vest (subject to paragraphs 4 and 5 below) to the extent set out below by reference to the average Share Price calculated over the 3 calendar months ending on 31 March 2024, where:

"Share Price" means the closing price of a Share in the Company;

Percentage of Award subject to the Share Price measure that will Vest

Share Price

0%

Less than 120 pence

20%

120 pence

Between 20% and 100% determined on a straight-line basis

Between 120 pence and 180 pence

100%

180 pence

 

The Directors may make such adjustments as they consider appropriate to the Share Price measure if any of the events described in rule 5.3.1 (i) to (iv) (inclusive) (Adjustment of Awards) of the Plan occurs before the measurement date.

 

4 The Directors have discretion to reduce (including to nil) the percentage of an Award which Vests if they consider that:

· NAV Growth and/or Share Price has been achieved as a result of inappropriate financial risk; or

· the level of the Company's financial and/or business risk is not in accordance with its stated strategy or;

· the outcome does not reflect the underlying financial or non-financial performance of the participant or the Group over the relevant period; or

· such vesting level is not appropriate in the context of circumstances that were unexpected or unforeseen at the grant date; or

· there exists any other reason why an adjustment is appropriate.

 

When exercising this discretion the Directors may take into account such factors as they consider relevant.

 

5 The Directors have discretion to reduce (including to nil) the percentage of a Tranche which Vests if they consider that the Participant's conduct prior to Vesting has not met the Group's organisational standards.

6 An Award will lapse to the extent that it does not Vest.

7 If, under the Plan rules, an Award vests early, the Directors will determine the extent to which the Performance Condition has been satisfied. As part of such determination, the Directors may, without limitation, take into account any information it considers appropriate including but not limited to the Company's most recent results and/or management accounts.

 

For further information please contact:-

 

Chris Barton

Company Secretary

020 7828 4777

29 June 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASKNALKFEFA
Date   Source Headline
25th Jun 20199:27 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSAnnual Financial Report
21st Jun 201910:13 amRNSHolding(s) in Company
22nd May 20193:42 pmRNSSupplemental Dividend Record Date clarification
22nd May 20197:00 amRNSResults for the 13-months ended 31 March 2019
10th Apr 20193:16 pmRNSBlock listing Interim Review
3rd Apr 201912:19 pmRNSDirector Declaration
3rd Apr 20197:00 amRNSAppointment of Independent Non-Executive Director
28th Feb 20195:01 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSAcquisition of Pure Gym unit in Finchley
22nd Feb 20197:00 amRNSDevelopment and Trading Update
15th Feb 20197:55 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSDisposal and Acquisition
22nd Jan 20197:00 amRNSNew Trading Opportunities
21st Jan 20199:19 amRNSDirector/PDMR Shareholding
17th Jan 20194:46 pmRNSDirector/PDMR Shareholding
8th Jan 20199:18 amRNSDirector/PDMR Shareholding
20th Dec 20182:10 pmRNSDirector/PDMR Shareholding
18th Dec 20184:07 pmRNSHolding(s) in Company
18th Dec 201810:15 amRNSDirector/PDMR Shareholding
17th Dec 20188:52 amRNSDirector/PDMR Shareholding
17th Dec 20187:00 amRNSBlock listing Interim Review
15th Nov 201812:02 pmRNSDirector/PDMR Shareholding
5th Nov 201812:57 pmRNSHolding(s) in Company
30th Oct 20187:00 amRNSPlanning consent secured at Hendy Wind Farm
24th Oct 20187:00 amRNSInterim Results
15th Oct 20189:53 amRNSU+I Employee Benefit Trust - Purchase of Shares
10th Oct 20182:36 pmRNSBlock listing Interim Review
25th Sep 20187:00 amRNSPlanning approved at Kensington Church Street
31st Aug 20189:41 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
17th Jul 201812:01 pmRNSDirector/PDMR Shareholding
17th Jul 201811:59 amRNSDirector/PDMR Shareholding
17th Jul 201811:59 amRNSDirector/PDMR Shareholding
9th Jul 20182:14 pmRNSDirector/PDMR Shareholding
5th Jul 20184:16 pmRNSAGM Statement
4th Jul 20188:00 amRNSDeputy Chief Executive to take a short sabbatical
2nd Jul 20187:00 amRNSU+I selected for major Cambridge development
2nd Jul 20187:00 amRNSTotal Voting Rights
29th Jun 20184:35 pmRNSBlock listing Interim Review
27th Jun 20187:00 amRNSBlock Listing
11th Jun 20189:51 amRNSHolding(s) in Company
8th Jun 20183:57 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSEBT share transfer and purchase, and voting rights
29th May 20184:53 pmRNSHolding(s) in Company
22nd May 201811:24 amRNSDirector/PDMR Shareholding
22nd May 201811:24 amRNSDirector/PDMR Shareholding
22nd May 201811:22 amRNSDirector/PDMR Shareholding
22nd May 201810:10 amRNSAnnual Financial Report
4th May 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.